Announcements

  • FDA approves Prevymis to prevent cytomegalovirus following bone marrow transplant

    8 years ago
    The FDA today approved tablets and injection, the first treatment indicated for cytomegalovirus prophylaxis in adults who have been exposed to cytomegalovirus and underwent an allogeneic hematopoietic stem cell transplant.